In gastric cancer, SATB1 expression has been reported to correlate with a more malignant phenotype and poor prognosis whereas in squamous cell carcinoma of the lung, downregulation of SATB1 was demonstrated to be associated with an impaired survival [27]. This evidence concerns the gene SATB1 and squamous cell lung carcinoma.